ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

ClinicalTrials.gov ID: NCT03362177

Public ClinicalTrials.gov record NCT03362177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RECITE: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy- Induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer

Study identification

NCT ID
NCT03362177
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
165 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2019
Primary completion
Jan 24, 2024
Completion
Jan 8, 2025
Last update posted
Feb 10, 2026

2019 – 2025

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Saint Bernards Medical Center Jonesboro Arkansas 72401
Pacific Cancer Medical Center Inc Anaheim California 92801
University of California Irvine Orange California 92868
Colorado West Healthcare System dba Grand Valley Oncology Grand Junction Colorado 81505
Mid Florida Hematology and Oncology Centers PA Orange City Florida 32763
Oncology and Hematology Associates of West Broward, PA Tamarac Florida 33321
Cleveland Clinic Florida Weston Florida 33331
Orchard Healthcare Research Inc Skokie Illinois 60076
Christus Saint Frances Cabrini Hospital Alexandria Louisiana 71301
University Medical Center New Orleans New Orleans Louisiana 70112
Christus Highland Cancer Treatment Center Shreveport Louisiana 71105
Mercy Medical Center Baltimore Maryland 21202
American Oncology Partners, PA Bethesda Maryland 20817
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Hattiesburg Clinic Hematology/Oncology Hattiesburg Mississippi 39401
Oncology Hematology Associates Springfield Missouri 65807
Morristown Medical Center Morristown New Jersey 07960
Regional Cancer Care Associates Sparta New Jersey 78071
The Center for Cancer and Blood Disorders Fort Worth Texas 76104
Medical Oncology Associates PS Spokane Washington 99208
Yakima Valley Memorial Hospital Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03362177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03362177 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →